For bona fide cell-associated cancer markers such as Her-2, there is persuasive evidence that at least a fragment of the protein molecule is released into the plasma and can be detected as a cancer biomarker (Tse et al. 2005), and other proteins documented here in the tissues of cancer patients have been demonstrated to be found in plasma in other disease indications. The gene discussed is ERBB2; the disease is cancer.